T. Alanko et O. Saksela, Transforming growth factor beta 1 induces apoptosis in normal melanocytes but not in nevus cells grown in type I collagen gel, J INVES DER, 115(2), 2000, pp. 286-291
We used type I collagen gel cultures to compare the growth requirements of
melanocytes and dermal nevus cells. Melanocytes but not nevus cells undergo
apoptosis in collagen unless supplied with growth stimulators such as fibr
oblast growth factor 2. To characterize the mechanism of melanocyte apoptos
is in collagen, we tested the effects of transforming growth factor beta 1,
known to be functionally active in the skin. When picomolar amounts of tra
nsforming growth factor beta 1 were added to normal melanocytes grown in ty
pe I collagen gel, their apoptosis was dramatically accelerated. In contras
t, the apoptotic rate of nevus cells and melanoma cells grown under similar
conditions was not affected by transforming growth factor beta 1. The incr
eased apoptosis of normal melanocytes was effectively counteracted by addit
ion of either neutralizing transforming growth factor beta 1 antibodies or
fibroblast growth factor 2 to the collagen gel. Interestingly, the backgrou
nd apoptosis of normal melanocytes was also inhibited by transforming growt
h factor beta 1 antibodies. By Western blotting we detected transforming gr
owth factor beta-like immunoreactivity in melanocyte, nevus cell, and melan
oma cell lysates. A sensitive bioassay confirmed that their medium containe
d considerable amounts of heat-activatable growth inhibitory activity that
could partly be neutralized by transforming growth factor beta 1 antibodies
. It is evident that apoptosis of melanocytes grown in type I collagen gel
can be mediated by both endogenous and exogenous transforming growth factor
beta. We suggest that the balance between inhibitory growth factors such a
s transforming growth factor beta and stimulatory growth factors like fibro
blast growth factor 2 has the potential to regulate the growth, localizatio
n, and survival of normal melanocytes also in vivo. The resistance of nevus
cells to transforming-growth-factor-beta-mediated apoptosis may facilitate
their ability to grow in the dermal compartment of the skin.